{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T08:30:33Z","timestamp":1743841833815},"reference-count":44,"publisher":"Georg Thieme Verlag KG","issue":"03","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z Geburtshilfe Neonatol"],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>\n          Objective To evaluate the serum vasostatin-1 levels in preeclamptic and\n                    non-preeclamptic pregnant women.<\/jats:p><jats:p>\n          Materials and methods Thirty consecutive women with mild preeclampsia and\n                    sixty consecutive women with severe preeclampsia were compared with ninety\n                    gestational age-matched (\u00b11 week) non-preeclamptic pregnant women with\n                    an appropriate-for-gestational-age (AGA) fetus.<\/jats:p><jats:p>\n          Results Mean serum vasostatin-1 was significantly higher in women with\n                    preeclampsia than gestational age-matched controls. Mean serum vasostatin-1 was\n                    significantly higher in the mild preeclampsia group compared to its gestational\n                    age-matched control group, and in the severe preeclampsia group compared to its\n                    gestational age-matched control group. There was no significant difference in\n                    mean serum vasostatin-1 levels between the mild and severe preeclampsia groups,\n                    and in severe early- and severe late-onset preeclampsia groups. Serum\n                    vasostatin-1 had positive correlations with systolic and diastolic blood\n                    pressure.<\/jats:p><jats:p>\n          Conclusion Serum vasostatin-1 was significantly higher in women with\n                    preeclampsia compared to those of the gestational age-matched controls. There\n                    was no significant difference in mean serum vasostatin-1 levels between the mild\n                    and severe preeclampsia groups and severe early- and severe late-onset\n                    preeclampsia groups.<\/jats:p>","DOI":"10.1055\/a-1747-3738","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T01:17:13Z","timestamp":1645233433000},"page":"178-185","source":"Crossref","is-referenced-by-count":1,"title":["Serum Vasostatin-1 Level is Increased in Women with\n                    Preeclampsia"],"prefix":"10.1055","volume":"226","author":[{"given":"Abdullah","family":"T\u00fcten","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Istanbul University Cerrahpasa Faculty of\n                    Medicine, Fatih, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin","family":"T\u00fcten","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynecology, Istanbul Kanuni Sultan Suleyman Training and\n                    Research Hospital, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koray","family":"G\u00f6k","sequence":"additional","affiliation":[{"name":"Perinatology, Sakarya Training and Research Hospital, Sakarya,\n                    Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kubra","family":"Hamzaoglu","sequence":"additional","affiliation":[{"name":"Obstetric and Gynecology, Istanbul Universitesi-Cerrahpasa, Istanbul,\n                    Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huri","family":"Bulut","sequence":"additional","affiliation":[{"name":"Biochemistry, Istinye University, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduard","family":"Malik","sequence":"additional","affiliation":[{"name":"University Hospital for Obstetrics and Gynecology, Carl von Ossietzky\n                    University of Oldenburg, Oldenburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Guralp","sequence":"additional","affiliation":[{"name":"University Hospital for Obstetrics and Gynecology, Carl von Ossietzky\n                    University of Oldenburg, Oldenburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/CIRCRESAHA.118.313276","article-title":"Preeclampsia: pathophysiology, challenges, and perspectives","volume":"124","author":"S Rana","year":"2019","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MNH.0000000000000105","article-title":"Pathogenesis of preeclampsia","volume":"24","author":"M T Sircar","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"J M Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1515\/jpme.1996.24.2.119","article-title":"Endothelial dysfunction in preeclampsia. Part I: Primary prevention. Therapeutic\n                    perspectives","volume":"24","author":"G A Dekker","year":"1996","journal-title":"J Perinat Med"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvp266","article-title":"The chromogranin A-derived peptides vasostatin-I and catestatin as regulatory\n                    peptides for cardiovascular functions","volume":"85","author":"K B Helle","year":"2010","journal-title":"Cardiovasc Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1748-1716.1994.tb09780.x","article-title":"Vasoinhibitory activity of synthetic peptides from the amino terminus of\n                    chromogranin A","volume":"152","author":"R H Angeletti","year":"1994","journal-title":"Acta Physiol Scand"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.regpep.2006.04.007","article-title":"The chromogranin A peptide vasostatin-I inhibits gap formation and signal\n                    transduction mediated by inflammatory agents in cultured bovine pulmonary and\n                    coronary arterial endothelial cells","volume":"135","author":"A Blois","year":"2006","journal-title":"Regul Pept"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1096\/fj.03-0922fje","article-title":"Chromogranin A protects vessels against tumor necrosis factor alpha-induced\n                    vascular leakage","volume":"18","author":"E Ferrero","year":"2004","journal-title":"FASEB J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.jid.5700484","article-title":"Novel anti-inflammatory properties of the angiogenesis inhibitor vasostatin","volume":"127","author":"R Huegel","year":"2007","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood-2012-05-430314","article-title":"A new chromogranin A-dependent angiogenic switch activated by thrombin","volume":"121","author":"L Crippa","year":"2013","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on\n                    pre-eclampsia: a pragmatic guide for first-trimester screening and\n                    prevention","volume":"145 Suppl 1","author":"L C Poon","year":"2019","journal-title":"Int J Gynaecol Obstet"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1001\/jama.287.24.3183","article-title":"Contemporary concepts of the pathogenesis and management of preeclampsia","volume":"287","author":"K Y Lain","year":"2002","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/1471-0528.16537","article-title":"The placenta is the villain or victim in the pathogenesis of pre-eclampsia: FOR:\n                    The placenta is the villain in the pathogenesis of preeclampsia","volume":"128","author":"P Murthi","year":"2021","journal-title":"BJOG"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to\n                    the great obstetrical syndromes","volume":"221","author":"I Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jri.2019.07.004","article-title":"The two-stage placental model of preeclampsia: an update","volume":"134\u2013135","author":"A C Staff","year":"2019","journal-title":"J Reprod Immunol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0002-9378(99)70239-5","article-title":"Preeclampsia: an excessive maternal inflammatory response to pregnancy","volume":"180","author":"C W Redman","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajh\/4.8.700","article-title":"Clinical and biochemical evidence of endothelial cell dysfunction in the\n                    pregnancy syndrome preeclampsia","volume":"4","author":"J M Roberts","year":"1991","journal-title":"Am J Hypertens"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1016\/S0021-9258(19)49853-0","article-title":"Angiogenesis","volume":"267","author":"J Folkman","year":"1992","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"354359","DOI":"10.1155\/2015\/354359","article-title":"Normal and pathological placental angiogenesis","volume":"2015","author":"N Bardin","year":"2015","journal-title":"Biomed Res Int"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"S Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to\n                    endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"S E Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1056\/NEJMoa055352","article-title":"Soluble endoglin and other circulating anti-angiogenic factors in\n                    preeclampsia","volume":"355","author":"R J Levine","year":"2006","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"28.e1","DOI":"10.1016\/j.ajog.2007.04.010","article-title":"Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in\n                    hypertensive diseases of pregnancy","volume":"197","author":"S Salahuddin","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"R J Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","article-title":"Angiogenic factors and the risk of adverse outcomes in women with suspected\n                    preeclampsia","volume":"125","author":"S Rana","year":"2012","journal-title":"Circulation"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1096\/fj.06-6829com","article-title":"The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial\n                    cell proliferation and migration","volume":"21","author":"D Belloni","year":"2007","journal-title":"FASEB J"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1096\/fj.11-182410","article-title":"The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in\n                    hypoxia-driven endothelial cells and regulates tumor neovascularization","volume":"25","author":"L Veschini","year":"2011","journal-title":"FASEB J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3109\/10641955.2013.837173","article-title":"The comparison of endogenous angiogenesis inhibitors in normotensive and\n                    preeclamptic placentas: an immunohistochemical study","volume":"33","author":"E Ayaz","year":"2014","journal-title":"Hypertens Pregnancy"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/en.2012-2210","article-title":"Full-length human chromogranin-A cardioactivity: myocardial, coronary, and\n                    stimulus-induced processing evidence in normotensive and hypertensive male rat\n                    hearts","volume":"154","author":"T Pasqua","year":"2013","journal-title":"Endocrinology"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/apha.12628","article-title":"Endothelium-dependent hyperpolarization: age, gender and blood pressure, do they\n                    matter?","volume":"219","author":"S W Leung","year":"2017","journal-title":"Acta Physiol (Oxf)"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"C Weber","year":"2011","journal-title":"Nat Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.3390\/ijms19061740","article-title":"Classical risk factors and inflammatory biomarkers: one of the missing\n                    biological links between cardiovascular disease and major depressive\n                    disorder","volume":"19","author":"T C Baghai","year":"2018","journal-title":"Int J Mol Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.3389\/fphar.2019.01568","article-title":"Role of endothelial dysfunction in cardiovascular diseases: the link between\n                    inflammation and hydrogen sulfide","volume":"10","author":"H J Sun","year":"2019","journal-title":"Front Pharmacol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3389\/fchem.2014.00064","article-title":"The surging role of Chromogranin A in cardiovascular homeostasis","volume":"2","author":"B Tota","year":"2014","journal-title":"Front Chem"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.2174\/092986712802430009","article-title":"Chromogranin-A: a multifaceted cardiovascular role in health and disease","volume":"19","author":"T Angelone","year":"2012","journal-title":"Curr Med Chem"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0167-0115(92)90509-S","article-title":"The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and\n                    its independence of extracellular calcium in isolated segments of human blood\n                    vessels","volume":"41","author":"S Aardal","year":"1992","journal-title":"Regul Pept"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1007\/s00018-007-7254-0","article-title":"The endocrine role for chromogranin A: a prohormone for peptides with regulatory\n                    properties","volume":"64","author":"K B Helle","year":"2007","journal-title":"Cell Mol Life Sci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.pneurobio.2017.04.003","article-title":"Granin-derived peptides","volume":"154","author":"J Troger","year":"2017","journal-title":"Prog Neurobiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"41725","DOI":"10.18632\/oncotarget.9407","article-title":"Inhibition of chronic lymphocytic leukemia progression by full-length\n                    chromogranin A and its N-terminal fragment in mouse models","volume":"7","author":"M Bianco","year":"2016","journal-title":"Oncotarget"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s10620-012-2031-9","article-title":"The N-terminal fragment of chromogranin A, vasostatin-1 protects mice from acute\n                    or chronic colitis upon oral administration","volume":"57","author":"C Rumio","year":"2012","journal-title":"Dig Dis Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1096\/fj.201802707R","article-title":"Physiological levels of chromogranin A prevent doxorubicin-induced\n                    cardiotoxicity without impairing its anticancer activity","volume":"33","author":"C Rocca","year":"2019","journal-title":"FASEB J"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1161\/HYPERTENSIONAHA.115.05024","article-title":"Preeclampsia and pregnancy-related hypertensive disorders","volume":"67","author":"S A Karumanchi","year":"2016","journal-title":"Hypertension"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/HJH.0000000000001901","article-title":"Sympathetic nervous system control of vascular function and blood pressure\n                    during pregnancy and preeclampsia","volume":"37","author":"F T Spradley","year":"2019","journal-title":"J Hypertens"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1053\/euhj.2001.2977","article-title":"Chromogranin A in heart failure; a novel neurohumoral factor and a predictor for\n                    mortality","volume":"23","author":"C Ceconi","year":"2002","journal-title":"Eur Heart J"}],"container-title":["Zeitschrift f\u00fcr Geburtshilfe und Neonatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-1747-3738.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T23:27:56Z","timestamp":1655249276000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-1747-3738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":44,"journal-issue":{"issue":"03","published-online":{"date-parts":[[2022,6,14]]},"published-print":{"date-parts":[[2022,6]]}},"URL":"https:\/\/doi.org\/10.1055\/a-1747-3738","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0948-2393","1439-1651"],"issn-type":[{"value":"0948-2393","type":"print"},{"value":"1439-1651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]}}}